|1.||Breithardt, Günter: 8 articles (04/2012 - 01/2002)|
|2.||Eckardt, Lars: 7 articles (04/2012 - 01/2002)|
|3.||Milberg, Peter: 5 articles (04/2012 - 04/2003)|
|4.||Dorian, Paul: 5 articles (01/2011 - 01/2002)|
|5.||Singh, Steven N: 5 articles (02/2009 - 08/2003)|
|6.||Tang, X Charlene: 5 articles (02/2009 - 08/2003)|
|7.||Singh, Bramah N: 5 articles (02/2009 - 08/2003)|
|8.||Meijboom, E J: 5 articles (03/2003 - 03/2000)|
|9.||Lafuente-Lafuente, Carmelo: 4 articles (01/2015 - 04/2006)|
|10.||Oudijk, M A: 4 articles (09/2013 - 06/2000)|
07/01/2000 - "Administration of intravenous sotalol was effective in preventing early reinitiation of atrial fibrillation in five of seven (71%) patients where pacing failed to suppress early reinitiation of atrial fibrillation. "
11/01/1997 - "Is oral sotalol effective in converting atrial fibrillation to sinus rhythm?"
04/01/1997 - "On subanalysis, sotalol was shown to be effective in the prophylaxis of both paroxysmal atrial fibrillation and paroxysmal reentrant arrhythmias. "
09/01/1993 - "A larger dose of sotalol (cumulative dose, 8 mg/kg) was uniformly effective in terminating atrial fibrillation and preventing its induction. "
02/01/1993 - "Sotalol was effective in reducing the incidence of atrial fibrillation. "
09/01/1987 - "In preliminary studies sotalol appeared effective in most forms of supraventricular tachyarrhythmias with its effects being similar to those of other beta-blockers. "
07/01/1987 - "In contrast, sotalol was highly effective in preventing the induction of reentrant ventricular tachyarrhythmias. "
10/01/2011 - "High-dose sotalol is safe and effective in neonates and infants with refractory supraventricular tachyarrhythmias."
12/01/2001 - "Sotalol, being an effective and safe drug particularly in children, is a good therapeutic alternative for the preventive treatment of childhood tachyarrhythmias."
09/01/2011 - "Sotalol is more effective in the prevention of supraventricular tachyarrhythmia than placebo or beta-blockers. "
11/01/1995 - "It is concluded that d/l sotalol is highly effective in the suppression of sustained monomorphic ventricular tachycardia inducible by programmed electrical stimulation. "
07/01/1992 - "Thus, in arrhythmogenic right ventricular disease, sotalol proved to be highly effective in patients with inducible as well as noninducible ventricular tachycardia. "
05/01/1998 - "Following sotalol with-drawal polymorphic ventricular tachycardia resolved completely. "
11/01/1985 - "Eighteen patients with sustained ventricular tachycardia underwent serial electrophysiological studies to establish the therapeutic efficacy of sotalol as compared to other available anti-arrhythmic agents. "
03/01/1984 - "Eighteen patients with sustained ventricular tachycardia underwent electrophysiologic studies to establish the therapeutic efficacy of sotalol. "
|4.||Cardiac Arrhythmias (Arrythmia)
11/01/1993 - "With multivariate testing of 14 variables, only sotalol therapy and absence of prior antiarrhythmic therapy were associated with a significant reduction in risk of arrhythmia recurrence."
04/15/1997 - "To further evaluate the relative efficacy of d,I-sotalol compared with class I drugs, and to assess the relative importance of its class II (beta-blocking) and class III effects, 6-year arrhythmia recurrence and mortality in patients receiving sotalol were compared with those in patients receiving class I drugs, subdivided according to whether they also received coadministered beta blockers. "
01/15/1995 - "Extrapolation of these data to a clinical setting may explain the efficacy of dl-sotalol in diminishing ventricular arrhythmia recurrence."
07/01/1994 - "[Efficacy of sotalol in idiopathic ventricular arrhythmia originating in the right ventricular outflow tract]."
03/01/2001 - "This pharmacokinetic-pharmacodynamic study was designed to define the steady-state relationship between pharmacologic response and dose or concentration of sotalol in children with cardiac arrhythmias, with an emphasis on neonates and infants. "
11/01/1991 - "Sotalol, a nonselective beta blocking agent with additional Class III activity has been shown to be extremely effective in the treatment of supraventricular tachycardias in adults and children. "
12/01/2001 - "Sotalol was more effective in re-entrant type supraventricular tachycardias (P=0.012). "
09/01/1985 - "Thus, sotalol is effective in the therapy of patients with recurrent supraventricular tachycardias."
10/04/2005 - "Development of a safe and effective pediatric dosing regimen for sotalol based on population pharmacokinetics and pharmacodynamics in children with supraventricular tachycardia."
02/15/1992 - "The efficacy of intravenous sotalol (1 mg/kg) for suppressing inducibility of supraventricular tachycardias (SVT) with different electrophysiologic mechanisms was studied in 30 consecutive patients referred for an electrophysiologic study because of paroxysmal SVT. "
|1.||Electric Countershock (Cardioversion)
|2.||Drug Therapy (Chemotherapy)
|3.||Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
|4.||Coronary Artery Bypass (Coronary Artery Bypass Surgery)